749269-83-8 Usage
Uses
Used in Respiratory Disease Treatment:
CHF 5074 is used as an anti-inflammatory and bronchodilatory agent for the treatment of respiratory diseases such as chronic obstructive pulmonary disease (COPD) and asthma. It inhibits the production of inflammatory mediators and reduces airway inflammation in animal models, suggesting its potential as a new therapy for these conditions.
Used in Improving Lung Function:
CHF 5074 is used to improve lung function in patients with respiratory diseases. Its bronchodilatory effects help reduce airway hyperresponsiveness, further supporting its potential as a therapeutic agent for respiratory conditions.
Used in Pharmaceutical Industry:
In the pharmaceutical industry, CHF 5074 is used as a research compound for the development of new therapies targeting respiratory diseases. Its ability to inhibit PDE4 and reduce inflammation makes it a valuable asset in the search for more effective treatments for COPD and asthma.
Check Digit Verification of cas no
The CAS Registry Mumber 749269-83-8 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 7,4,9,2,6 and 9 respectively; the second part has 2 digits, 8 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 749269-83:
(8*7)+(7*4)+(6*9)+(5*2)+(4*6)+(3*9)+(2*8)+(1*3)=218
218 % 10 = 8
So 749269-83-8 is a valid CAS Registry Number.
749269-83-8Relevant academic research and scientific papers
1-(2-FLUOROBIPHENYL-4-YL)-ALKYL CARBOXYLIC ACID DERIVATIVES FOR THE THERAPY OF TRANSTHYRETIN AMYLOIDOSIS
-
, (2011/11/06)
Derivatives of 1-(2-fluorobiphenyl-4-yl)-alkyl carboxylic acid are capable of stabilizing the tetrameric native state of transthyretin for the prophylaxis and treatment of amyloidosis.
1-PHENYLALKANECARBOXYLIC ACID DERIVATIVES FOR THE TREATMENT OF NEURODEGENERATIVE DISEASES
-
Page 16, (2010/02/08)
1-Phenylalkanecarboxylic acid derivatives, the processes for the preparation thereof and the use thereof in the treatment and/or prevention of neurodegenerative diseases such as Alzheimer's disease.
